Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Operating Expenses | 33,601 | 19,962 | 4,537 | 2,120 | 0 |
| Operating Income | -33,601 | -19,962 | -4,537 | -2,120 | N/A |
| Interest Expense | 20 | 0 | 0 | 0 | 0 |
| Other Income | 653 | 692 | -2 | 0 | 0 |
| Pre-tax Income | -32,968 | -19,270 | -4,539 | -2,120 | 0 |
| Net Income Continuous | -32,968 | -19,270 | -4,539 | -2,120 | N/A |
| Net Income | $-32,968 | $-19,270 | $-4,539 | $-2,120 | $N/A |
| EPS Basic Total Ops | -32.32 | -21.12 | -7.52 | -3.52 | N/A |
| EPS Basic Continuous Ops | -32.38 | -21.16 | -7.50 | -3.58 | N/A |
| EPS Diluted Total Ops | -32.32 | -21.12 | -7.52 | -3.52 | N/A |
| EPS Diluted Continuous Ops | -32.38 | -21.16 | -7.50 | -3.58 | N/A |
| EPS Diluted Before Non-Recurring Items | -32.32 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-33,445 | $-19,945 | $-4,536 | $-2,120 | $N/A |